Shoulder Innovations, Inc. (SI)
| Market Cap | 264.32M |
| Revenue (ttm) | 41.63M +116.0% |
| Net Income | -36.38M |
| EPS | -10.36 |
| Shares Out | 20.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 39,904 |
| Open | 12.76 |
| Previous Close | 12.74 |
| Day's Range | 12.40 - 13.29 |
| 52-Week Range | 10.92 - 17.94 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 20.60 (+60.56%) |
| Earnings Date | Apr 17, 2026 |
About SI
Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States. It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion. The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan. [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for SI stock is "Strong Buy." The 12-month stock price target is $20.6, which is an increase of 60.56% from the latest price.
News
Shoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO
Shoulder Innovations, which offers advanced implant systems for shoulder arthroplasty, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
Shoulder Innovations IPO Registration Document (S-1)
Shoulder Innovations has filed to go public with an IPO on the New York Stock Exchange (NYSE).